Skip to main content
All lobbying filings

BALLARD PARTNERS

BALLARD PARTNERS filed a Q2 termination report for GENETIX BIOTHERAPEUTICS INC. on October 16, 2026, reporting $80,000 in lobbying income.

Lobbying for GENETIX BIOTHERAPEUTICS INC. · Biotechnology company

All filings by BALLARD PARTNERS · Everything GENETIX BIOTHERAPEUTICS INC. has reported

 Filing · LD-2 quarterly report Q2 termination
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Oct 16, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Representation ended
May 31, 2026
The registrant reported terminating its work for this client.

Official filing document

 Lobbyists on this filing 2
  • ALISON ANWAY
    Previously held: LA to Senator Pat Roberts 2006-2010
  • TOLA THOMPSON
    Previously held: Communications Director and Senior Legislative Assistant to U.S. Representative Carrie Meek (1993-2002); Chief of Staff to U.S. Representative Al Lawson (2017-2021)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Advocacy regarding an FDA issue.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem